Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/28/20 → 8/28/23 |
Funding
- Medpace Clinical Research LLC (Prot #ACE1702-001)
- Acepodia Biotech, Inc. (Prot #ACE1702-001)
Prot #ACE1702-001: A Phase I, Open Label, Dose Escalation Study of ACE1702 Cell Immunotherapy in Subjects with Advanced or Metastatic HER2-expressing Solid Tumors
- Mahalingam, Devalingam (PD/PI)
Project: Research project